Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is common among cancer patients treated with neurotoxic chemotherapy agents. Better knowledge on symptom clusters of CIPN may help improve symptom management in clinical practice. This study aimed to identify symptom clusters of CIPN and to map their trajectories before initiation of chemotherapy to 12-month follow-up. Methods: A secondary analysis of a longitudinal dataset was conducted using principal component approach. The European Organization for the Research and Treatment of Cancer Quality of Life Questionnaires Core 30 and CIPN 20 were used to measure symptom clusters of CIPN in patients with mixed cancer diagnosis across 10 time points over 12 months. Results: Sample size in each assessment point ranged from 118 to 343 participants. Four CIPN symptom clusters were identified, including a clear sensory neuropathy symptom cluster, a mixed motor-sensory neuropathy symptom cluster, a mixed sensorimotor neuropathy symptom cluster, and a less clear autonomic neuropathy symptom cluster. The core symptoms in each symptom cluster were mostly stable while the secondary symptoms changed over time. Conclusions: The analysis suggests that CIPN is predominantly a sensory neuropathy with no evidence of a pure motor dysfunction but with mixed motor-related and autonomic changes accompanying sensory dysfunctions over time. Future symptom management strategies can be designed based on the morphology of CIPN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Platinum analogs, taxanes, vinca alkaloids, and proteasome inhibitors are the most common causative agents [41].”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quality of life research within the EORTC—the EORTC QLQ-C30
Fayers, P., & Bottomley, A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00448-8 · Cited by 924
Chemotherapy-induced peripheral neuropathy: a current review
Staff, N. P., Grisold, A., Grisold, W., & Windebank, A. J. (2017) · Annals of Neurology · doi:10.1002/ana.24951 · Cited by 908
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
Park, S. B., Goldstein, D., Krishnan, A. V., Lin, C. S., Friedlander, M. L., Cassidy, J., Koltzenburg, M., & Kiernan, M. C. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21204 · Cited by 741
Symptom Clusters: Concept Analysis and Clinical Implications for Cancer Nursing
Kim, H.-J., McGuire, D. B., Tulman, L., & Barsevick, A. M. (2005) · Cancer Nursing · doi:10.1097/00002820-200507000-00005 · Cited by 598
Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer
Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A. (2010) · Cancer · doi:10.1002/cncr.25098 · Cited by 513
Mols, F., Beijers, T., Vreugdenhil, G., & van de Poll-Franse, L. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2255-7 · Cited by 374
Winters-Stone, K. M., Horak, F., Jacobs, P. G., Trubowitz, P., Dieckmann, N. F., Stoyles, S., & Faithfull, S. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.3552 · Cited by 368
Pachman, D. R., Qin, R., Seisler, D. K., Smith, E. M. L., Beutler, A. S., Ta, L. E., Lafky, J. M., Wagner-Johnston, N. D., Ruddy, K. J., Dakhil, S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8533 · Cited by 309
Cavaletti, G., Cornblath, D. R., Merkies, I. S. J., Postma, T. J., Rossi, E., Frigeni, B., Alberti, P., Bruna, J., Velasco, R., Argyriou, A. A., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds329 · Cited by 293
Molassiotis, A., Cheng, H. L., Lopez, V., Au, J. S. K., Chan, A., Bandla, A., Leung, K. T., Li, Y. C., Wong, K. H., Suen, L. K. P., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5302-4 · Cited by 212
Self-citation
Cited by
Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy
Chen, X., Gan, Y., Au, N. P. B., & Ma, C. H. E. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1345811 · Cited by 108
A review of movement disorders in chemotherapy-induced neurotoxicity
Wang, A. B., Housley, S. N., Flores, A. M., Kircher, S. M., Perreault, E. J., & Cope, T. C. (2021) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-021-00818-2 · Cited by 61
Trendowski, M. R., Lusk, C. M., Ruterbusch, J. J., Seaton, R., Simon, M. S., Greenwald, M. K., Harper, F. W. K., Beebe‐Dimmer, J., & Schwartz, A. G. (2021) · Cancer Medicine · doi:10.1002/cam4.4328 · Cited by 51
Alberti, P., Bernasconi, D. P., Cornblath, D. R., Merkies, I. S. J., Park, S. B., Velasco, R., Bruna, J., Psimaras, D., Koeppen, S., Pace, A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012300 · Cited by 42
Eikeland, S. A., Smeland, K. B., Mols, F., Fagerli, U., Bersvendsen, H. S., Kiserud, C. E., & Fosså, A. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1917776 · Cited by 38
Metadata
- Authors
- Wang, M., Cheng, H. L., Lopez, V., Sundar, R., Yorke, J., & Molassiotis, A.
- Affiliations
- Hong Kong Polytechnic University (HK)
- National University of Singapore (SG)
- University of Manchester (GB)
- Corresponding author
- Molassiotis, Alex
- Venue
- BMC Cancer
- Published
- 2019-11-27
- Volume
- 19
- Issue
- 1
- Pages
- 1151-1151
- ISSN
- 1471-2407 (ISSN-L)
- PMC
- PMC6882224
- OpenAlex
- W2991056365
- Cited by
- 42
- References
- 37
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 10 · 2023: 5 · 2022: 7 · 2021: 9 · 2020: 1
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PolyU Institutional Research Archive (Hong Kong Polytechnic University) (submittedVersion, cc-by)
- National University of Singapore (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- This study was supported by a Polytechnic University Direct grant (in HK) and an NCIS Seed Funding Grant, National Medical Research Council (Singapore). (n/a)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Dermatology › Chemotherapy-related skin toxicity
- Keywords
- chemotherapy-induced peripheral neuropathy, symptom clusters, symptom trajectories, sensory neuropathy, autonomic neuropathy, sensorimotor dysfunction, patient-reported outcomes, EORTC QLQ-C30, cancer patients, symptom management
- MeSH terms
- Patient Reported Outcome Measures, Aged, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Female, Humans, Longitudinal Studies, Male, Middle Aged, Neoplasm Staging, Neoplasms, Peripheral Nervous System Diseases, Quality of Life, Surveys and Questionnaires, Cluster Analysis, Public Health Surveillance, Symptom Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time. https://app.cochat.ai/papers/10.1186/s12885-019-6352-3
- The paper
- Wang, M., Cheng, H. L., Lopez, V., Sundar, R., Yorke, J., & Molassiotis, A. (2019). Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time. BMC Cancer. https://doi.org/10.1186/s12885-019-6352-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.